Galapagos (GLPG) Set to Announce Quarterly Earnings on Thursday

Galapagos (NASDAQ:GLPG) is scheduled to announce its earnings results after the market closes on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.71) per share for the quarter.

Galapagos (NASDAQ:GLPG) opened at $115.22 on Thursday. Galapagos has a 1-year low of $67.30 and a 1-year high of $121.09. The stock has a market capitalization of $5,750.00, a price-to-earnings ratio of -122.64 and a beta of 0.87.

Several research analysts have issued reports on GLPG shares. BTIG Research reaffirmed a “buy” rating and set a $118.00 price objective on shares of Galapagos in a report on Thursday, February 8th. Stifel Nicolaus reaffirmed a “buy” rating and set a $120.00 price objective on shares of Galapagos in a report on Sunday, October 29th. BidaskClub raised Galapagos from a “hold” rating to a “buy” rating in a report on Wednesday, January 31st. Zacks Investment Research upgraded shares of Galapagos from a “sell” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, ValuEngine upgraded shares of Galapagos from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company. Galapagos presently has an average rating of “Buy” and an average price target of $111.00.

COPYRIGHT VIOLATION NOTICE: “Galapagos (GLPG) Set to Announce Quarterly Earnings on Thursday” was reported by Week Herald and is the sole property of of Week Herald. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://weekherald.com/2018/02/15/galapagos-glpg-set-to-announce-quarterly-earnings-on-thursday.html.

Galapagos Company Profile

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Earnings History for Galapagos (NASDAQ:GLPG)

Receive News & Ratings for Galapagos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply